Taro Kakikawa

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

Kenji Nonaka, Taro Kakikawa, Asako Sato et al. · Diabetes Research and Clinical Practice · 2008 · 206 citations

Medicine, Endocrinology, Pharmacology +12

Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study

Shinji Uchida, Tadaaki Taniguchi, Takafumi Shimizu et al. · Journal of Bone and Mineral Metabolism · 2005 · 71 citations

Medicine, Pharmacology, Pharmacotherapy +13

A Potent, Long-Acting, Orally Active (2<i>R</i>)-2-[(1<i>R</i>)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide:  A Novel Muscarinic M₃ Receptor Antagonist with High Selectivity for M₃ over M₂ Receptors

Morihiro Mitsuya, Kensuke Kobayashi, Kumiko Kawakami et al. · Journal of Medicinal Chemistry · 2000 · 46 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

A randomized, double-blind, placebo-controlled study of the effect of ezetimibe on glucose metabolism in subjects with type 2 diabetes mellitus and hypercholesterolemia

Itori Saito, Kyoichi Azuma, Taro Kakikawa et al. · Lipids in Health and Disease · 2015 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Lipid-modifying efficacy and tolerability of anacetrapib added to ongoing statin therapy in Japanese patients with dyslipidemia

Tamio Teramoto, Hiroyuki Daida, Katsunori Ikewaki et al. · Atherosclerosis · 2017 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17